# US 2026/0085369 A1 · KIT FOR RAPID DETECTION OF AVIAN LEUKOSIS VIRUS SUBGROUP J BASED ON CRISPR/Cas13a SYSTEM

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0085369 A1
- Document ID: US20260085369A1
- Status: Published application
- Kind: A1
- Application number: 19/080,176
- Filed: 2025-03-14
- Published: 2026-03-26
- Earliest claimed: 2024-09-26
- Assignees: Southwest University; ChongQing Academy of Animal Sciences
- Applicants: Southwest University; ChongQing Academy of Animal Sciences
- Inventors: Xi LAN; Qigui WANG; Haiwei WANG; Shutao CHEN; Min TAN; Zhifu CUI; Yongju ZHAO
- Web page: https://patentgrep.com/patent/US20260085369A1

## CPC

- C12Q 1/702: {for retroviruses}
- C12N 9/22: Ribonucleases {[RNase]; Deoxyribonucleases [DNase]}
- C12N 15/11: DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology, C07H21/00); {Non-coding nucleic acids having a biological activity}
- C12Q 1/6886: for cancer (immunoassay for cancer G01N33/575)
- C12Q 1/701: {Specific hybridization probes}
- C12N 2310/20: involving clustered regularly interspaced short palindromic repeats [CRISPR]
- C12N 2320/10: in screening processes
- C12Q 2600/158: Expression markers
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

Provided is a kit for rapid detection of avian leukosis virus subgroup J (ALV-J) based on a CRISPR/Cas13a system. The method is based on the combination of the CRISPR/Cas13a system and recombinase aided amplification (RAA) for ALV-J detection. An oligonucleotide probe is designed as a substrate for CRISPR/Cas13a trans-cleavage and produces a detectable signal. The method can substantially improve detection sensitivity by amplifying a detection signal twice by RAA and T7 transcription. The detection method further exhibits excellent specificity, allowing for clear differentiate from other avian viruses. It does not require expensive experimental equipment and special laboratory environment, and it is rapid and efficient. The method is of great significance for biological research and on-site detection of ALV-J.

## Claims

### Claim 1

A kit for rapid detection of avian leukosis virus subgroup J (ALV-J) based on a CRISPR/Cas13a system, wherein the kit comprises a recombinase aided amplification (RAA) reagent and a CRISPR-Cas13a detection reagent for T7 transcriptases;
the RAA reagent comprises a primer pair selected from the group consisting of a primer pair of SEQ ID NO: 1 and SEQ ID NO: 2, a primer pair of SEQ ID NO: 4 and SEQ ID NO: 5, and a primer pair of SEQ ID NO: 8 and SEQ ID NO: 9; and
the CRISPR-Cas13a detection reagent for T7 transcriptases comprises the T7 transcriptases, Cas13a, a fluorescent reporter gene, and crRNA primers; the fluorescent reporter gene has a sequence of SEQ ID NO: 23; and the crRNA primers are selected from the group consisting of a primer pair of SEQ ID NO: 13 and SEQ ID NO: 14, a primer pair of SEQ ID NO: 17 and SEQ ID NO: 18, and a primer pair of SEQ ID NO: 21 and SEQ ID NO: 22.

### Claim 2 (depends on 1)

The kit for rapid detection of ALV-J based on a CRISPR/Cas13a system according to claim 1, wherein the RAA reagent further comprises Reactive Powder, an RNA sample, an A buffer, and a B buffer.

### Claim 3 (depends on 1)

The kit for rapid detection of ALV-J based on a CRISPR/Cas13a system according to claim 1, wherein the CRISPR-Cas13a detection reagent for T7 transcriptases further comprises a Buffer, an RNA inhibitor, ribonucleoside triphosphate (rNTP), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), MgCl2, and RNA Target, and the RNA Target is an RAA product.

### Claim 4 (depends on 1)

The kit for rapid detection of ALV-J based on a CRISPR/Cas13a system according to claim 1, wherein the kit further comprises a lateral flow test strip comprising a conjugate pad zone, a test zone, and a control zone; the conjugate pad zone is immobilized with an RNA probe of 6-FAM-UUUUUUUUUUUUUU-C6 Biotin (SEQ ID NO: 24); the test zone comprises a test (T) line immobilized with a capture molecule capable of specifically binding to C6 Biotin on the probe; after a target RNA-probe complex is captured, the test zone on the test strip forms a fluorescent line or a color line; the control zone comprises a control (C) line immobilized with an anti-FAM antibody.

### Claim 5 (depends on 4)

The kit for rapid detection of ALV-J based on a CRISPR/Cas13a system according to claim 4, wherein the capture molecule is one selected from the group consisting of streptavidin and avidin.

### Claim 6 (depends on 1)

A method for in in vitro detection of ALV-J, comprising contacting a specimen with the kit according to claim 1.

### Claim 7 (depends on 6)

The method according to claim 6, wherein the RAA reagent further comprises Reactive Powder, an RNA sample, an A buffer, and a B buffer.

### Claim 8 (depends on 6)

The method according to claim 6, wherein the CRISPR-Cas13a detection reagent for T7 transcriptases further comprises a Buffer, an RNA inhibitor, ribonucleoside triphosphate (rNTP), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), MgCl2, and RNA Target, and the RNA Target is an RAA product.

### Claim 9 (depends on 6)

The method according to claim 6, wherein the kit further comprises a lateral flow test strip comprising a conjugate pad zone, a test zone, and a control zone; the conjugate pad zone is immobilized with an RNA probe of 6-FAM-UUUUUUUUUUUUUU-C6 Biotin (SEQ ID NO: 24); the test zone comprises a test (T) line immobilized with a capture molecule capable of specifically binding to C6 Biotin on the probe; after a target RNA-probe complex is captured, the test zone on the test strip forms a fluorescent line or a color line; the control zone comprises a control (C) line immobilized with an anti-FAM antibody

### Claim 10 (depends on 9)

The method according to claim 9, wherein the capture molecule is one selected from the group consisting of streptavidin and avidin.
